(VIANEWS) – Neurocrine Biosciences (NBIX), Interactive Brokers Group (IBKR), Flowserve Corporation (FLS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Neurocrine Biosciences (NBIX)
23.5% sales growth and 10.77% return on equity
Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products also include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; NBI-827104 to treat rare pediatric epilepsy and other indications; and crinecerfont. The company's products in clinical development also comprise NBI-1065844 for the treatment of negative symptoms of schizophrenia; NBI-1065845 for the treatment of resistant depression; and NBI-1065846 for treating anhedonia in depression. It has license and collaboration agreements with Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; AbbVie Inc.; and Sentia Medical Sciences Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Neurocrine Biosciences has a trailing twelve months EPS of $1.76.
PE Ratio
Neurocrine Biosciences has a trailing twelve months price to earnings ratio of 60.84. Meaning, the purchaser of the share is investing $60.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.77%.
Volume
Today’s last reported volume for Neurocrine Biosciences is 296077 which is 61.07% below its average volume of 760633.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.7%, now sitting on 1.67B for the twelve trailing months.
Moving Average
Neurocrine Biosciences’s value is higher than its 50-day moving average of $99.86 and higher than its 200-day moving average of $104.59.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 40.6% and 37.5%, respectively.
2. Interactive Brokers Group (IBKR)
15.6% sales growth and 20.78% return on equity
Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide. The company specializes in routing, executing, and processing trades in stocks, options, futures, foreign exchange instruments, bonds, mutual funds, exchange traded funds (ETFs), metals, and cryptocurrencies. It also custodies and services accounts for hedge and mutual funds, ETFs, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. In addition, it offers custody, prime brokerage, securities, and margin lending services. The company serves institutional and individual customers through approximately 150 electronic exchanges and market centers. Interactive Brokers Group, Inc. was founded in 1977 and is headquartered in Greenwich, Connecticut.
Earnings Per Share
As for profitability, Interactive Brokers Group has a trailing twelve months EPS of $2.84.
PE Ratio
Interactive Brokers Group has a trailing twelve months price to earnings ratio of 31.98. Meaning, the purchaser of the share is investing $31.98 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.78%.
Moving Average
Interactive Brokers Group’s worth is higher than its 50-day moving average of $86.26 and way above its 200-day moving average of $80.72.
Sales Growth
Interactive Brokers Group’s sales growth is 36.7% for the current quarter and 15.6% for the next.
3. Flowserve Corporation (FLS)
11.5% sales growth and 13.64% return on equity
Flowserve Corporation designs, develops, manufactures, distributes, and services industrial flow management equipment in the United States, Europe, the Middle East, Africa, Asia, and internationally. It operates in two segments, Flowserve Pump Division (FPD) and Flow Control Division (FCD). The FPD segment offers custom and pre-configured pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, upgrades, and related aftermarket services, including installation and commissioning services, seal systems spare parts, repairs, advanced diagnostics, re-rate and upgrade solutions, retrofit programs, and machining and asset management solutions, as well as manufactures a gas-lubricated mechanical seal for use in high-speed compressors for gas pipelines. The FCD segment provides engineered and industrial valve and automation solutions, including isolation and control valves, actuation, controls, and related equipment, as well as equipment maintenance services for flow control systems, including advanced diagnostics, repair, installation, commissioning, retrofit programs, and field machining capabilities. This segment's products are used to control, direct, and manage the flow of liquids, gases, and fluids. The company primarily serves oil and gas, chemical and pharmaceuticals, power generation, and water management markets, as well as general industries, including mining and ore processing, pulp and paper, food and beverage, and other smaller applications. The company distributes its products through direct sales, distributors, and sales representatives. Flowserve Corporation was incorporated in 1912 and is headquartered in Irving, Texas.
Earnings Per Share
As for profitability, Flowserve Corporation has a trailing twelve months EPS of $1.76.
PE Ratio
Flowserve Corporation has a trailing twelve months price to earnings ratio of 21.38. Meaning, the purchaser of the share is investing $21.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.64%.
4. Alphabet (GOOGL)
11.5% sales growth and 23.33% return on equity
Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, hardware, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube. It is also involved in the sale of apps and in-app purchases and digital content in the Google Play store; and Fitbit wearable devices, Google Nest home products, Pixel phones, and other devices, as well as in the provision of YouTube non-advertising services. The Google Cloud segment offers infrastructure, cybersecurity, data, analytics, AI, and machine learning, and other services; Google Workspace that include cloud-based collaboration tools for enterprises, such as Gmail, Docs, Drive, Calendar, and Meet; and other services for enterprise customers. The Other Bets segment sells health technology and internet services. The company was founded in 1998 and is headquartered in Mountain View, California.
Earnings Per Share
As for profitability, Alphabet has a trailing twelve months EPS of $4.77.
PE Ratio
Alphabet has a trailing twelve months price to earnings ratio of 28.71. Meaning, the purchaser of the share is investing $28.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.33%.
Moving Average
Alphabet’s worth is above its 50-day moving average of $125.19 and way above its 200-day moving average of $107.43.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Alphabet’s EBITDA is 5.36.
Sales Growth
Alphabet’s sales growth is 9.8% for the present quarter and 11.5% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 35.8% and 53.3%, respectively.
Previous days news about Alphabet(GOOGL)
- Alphabet (googl) boosts home app with automation features. According to Zacks on Tuesday, 29 August, "Consequently, this will help Alphabet win the confidence of the investors in the days ahead.", "Shares of Alphabet have gained 48.5% in the year-to-date period, outperforming the Computer and Technology sector’s rise of 35.8%."
- According to MarketWatch on Wednesday, 30 August, "OpenAI’s Sam Altman, Mark Zuckerberg of Meta Platforms Inc. , Tesla Inc.’s Elon Musk, Microsoft Corp.’s Satya Nadella, and Alphabet Inc.’s Sundar Pichai head the list of chief executives scheduled to meet Senate Majority Leader Chuck Schumer, D-N.Y., at his AI forum in Washington, D.C., on Sept. 13, according to Schumer’s office. "
- According to Zacks on Wednesday, 30 August, "Big technology companies like Alphabet are Nvidia’s ticket to even further sales and earnings growth."
- The zacks analyst blog highlights Alphabet, roche holding, honeywell international, IBM and the Goldman Sachs. According to Zacks on Tuesday, 29 August, "Stocks recently featured in the blog include: Alphabet Inc. (GOOGL Quick QuoteGOOGL – Free Report) , Roche Holding AG (RHHBY Quick QuoteRHHBY – Free Report) , Honeywell International Inc. (HON Quick QuoteHON – Free Report) , IBM Corp. (IBM Quick QuoteIBM – Free Report) and The Goldman Sachs Group, Inc. (GS Quick QuoteGS – Free Report) .", "(You can read the full research report on Alphabet here >>>)Shares of Roche have gained +4.3% over the past six months against the Zacks Large Cap Pharmaceuticals industry’s gain of +18.8%. "
5. Corporate Office Properties Trust (OFC)
5.9% sales growth and 11.16% return on equity
COPT is a REIT that owns, manages, leases, develops and selectively acquires office and data center properties. The majority of its portfolio is in locations that support the United States Government and its contractors, most of whom are engaged in national security, defense and information technology (“IT”) related activities servicing what the Company believes are growing, durable, priority missions (“Defense/IT Locations”). The Company also owns a portfolio of office properties located in select urban submarkets in the Greater Washington, DC/Baltimore region with durable Class-A office fundamentals and characteristics (“Regional Office Properties”). As of June 30, 2023, the Company derived 90% of its core portfolio annualized rental revenue from Defense/IT Locations and 10% from its Regional Office Properties. As of the same date and including 24 properties owned through unconsolidated joint ventures, COPT's core portfolio of 192 properties encompassed 22.9 million square feet and was 95% leased.
Earnings Per Share
As for profitability, Corporate Office Properties Trust has a trailing twelve months EPS of $1.7.
PE Ratio
Corporate Office Properties Trust has a trailing twelve months price to earnings ratio of 14.73. Meaning, the purchaser of the share is investing $14.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.16%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Corporate Office Properties Trust’s EBITDA is 7.22.
6. Baidu (BIDU)
5.7% sales growth and 6.8% return on equity
Baidu, Inc. offers internet search services in China. It operates through Baidu Core and iQIYI segments. The company offers Baidu App to access search, feed, and other services using mobile devices; Baidu Search to access its search and other services; Baidu Feed that provides users with personalized timeline based on their demographics and interests; Baidu Health that helps users to find the doctor and hospital for healthcare needs; and Haokan, a short video app. It also provides Baidu Knows, an online community where users can ask questions to other users; Baidu Wiki; Baidu Experience; Baidu Post; Baidu Wenku; Baidu Maps, a voice-enabled mobile app that provides travel-related services; Baidu Drive; Baijiahao; and DuerOS, a smart assistant platform. In addition, it offers online marketing services, which include pay for performance, an auction-based services that allow customers to bid for priority placement of paid sponsored links and reach users who search for information related to their products or services; other marketing services that include display-based marketing services and other online marketing services based on performance criteria other than cost per click; mobile ecosystem, a portfolio of apps, including Baidu App, Haokan, and Baidu Post; various cloud services and solutions, such as platform as a service, software as a service, and infrastructure as a service; self-driving services, including maps, automated valet parking, navigation pilot, electric vehicles, and robotaxi fleets, as well as Xiaodu smart devices. Further, the company provides iQIYI, an online entertainment service, including original and licensed content; other video content and membership; and online advertising services. Baidu, Inc. has strategic partnership with Zhejiang Geely Holding Group. The company was formerly known as Baidu.com, Inc. Baidu, Inc. was incorporated in 2000 and is headquartered in Beijing, China.
Earnings Per Share
As for profitability, Baidu has a trailing twelve months EPS of $6.05.
PE Ratio
Baidu has a trailing twelve months price to earnings ratio of 23.62. Meaning, the purchaser of the share is investing $23.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.8%.
Previous days news about Baidu(BIDU)
- : Baidu stock jumps as China-based search engine’s generative AI product ernie is now open to the public. According to MarketWatch on Wednesday, 30 August, "Shares of Baidu Inc. rallied 4.0% in afternoon trading Wednesday, after the China-based internet search and online marketing company said its generative artificial-intelligence (AI) product and language model, Ernie, is fully open to the public. ", "In addition, Baidu said the Ernie bot is set to launch new AI-native apps that allow users to the core abilities of generative AI, which are understanding, generation, reasoning and memory. "
7. HealthStream (HSTM)
5.1% sales growth and 3.86% return on equity
HealthStream, Inc. provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the range of its clinical development, talent management, training, certification, scheduling, competency assessment, performance appraisal, and other needs, as well as implementation and account management services. It also provides applications for learning, compensation management, succession planning, competency management, disclosure management, simulation-based education, quality management, and industry training. In addition, the company offers VerityStream that delivers enterprise-class solutions to transform the healthcare provider experience for ambulatory surgery centers, urgent care facilities, clinics, medical groups, and other healthcare organizations; EchoCredentialing and MSOW platforms that manage medical staff credentialing, enrollment, and privileging processes for hospitals; and EchoOneApp, a provider enrollment platform for medical groups. Further, it provides CredentialMyDoc, a credentialing and enrollment SaaS solution for medical groups and surgery centers; CredentialStream, a SaaS-based provider credentialing, privileging, and enrollment solution; and NurseGrid Mobile for nurse managers. The company offers its solutions in healthcare industry companies that include private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through direct sales teams. HealthStream, Inc. was incorporated in 1990 and is headquartered in Nashville, Tennessee.
Earnings Per Share
As for profitability, HealthStream has a trailing twelve months EPS of $0.42.
PE Ratio
HealthStream has a trailing twelve months price to earnings ratio of 50.76. Meaning, the purchaser of the share is investing $50.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.86%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
HealthStream’s EBITDA is 2.26.
Sales Growth
HealthStream’s sales growth is 3.3% for the ongoing quarter and 5.1% for the next.
